Babylon announced Thursday, its AI-powered symptom-checking chatbot is now integrated into Higi .’s mobile application.
The move comes months after the global digital health company ended the acquisition of Higi in early January. Higi do Approved by FDA Kiosks for grocery stores and pharmacies can check health metrics like blood pressure, pulse, and weight, and provide risk assessments. The company also offers a result tracking app.
“The integration with Higi is the first opportunity for established platform users to begin experiencing Babylon technology,” Babylon CEO and founder Ali Parsa said in a statement.
“Pairing the Symptom Checker, which is more focused on providing information to consumers’ immediate health needs, with Higi’s long-term view of patient health through testing Risk and vertical biometric tracking, is the first step towards adding additional tools to consumers’ toolkits that enable them to address their health needs proactively and holistically. “
WHY IT IMPORTANT
Babylon says the symptom-checking chatbot will help users narrow down potential illnesses and direct them to medical resources.
The integration with Higi will also demonstrate how future partners can use Babylon’s tools.
“There is so much knowledge we can offer consumers about their health,” Higi CEO Jeff Bennett said in a statement.
“The Symptom Checker is an incredible resource for our users, helping them start to see the benefits Babylon technology will add to our platform and creating new opportunities for Higi to serve.” our partners better with incremental solutions that enhance the consumer experience and connect consumers back to the care they may need.”
TREND TO BIGGER WOMAN
Babylon completed two consecutive acquisitions earlier this year. Immediately after Babylon ended its contract with Higi, the company announced that they have purchased the DayToDay Health patient interaction tool.
Originally launched in the UK, Babylon announced its move into the US market at the end of 2019. It went public last year through a merger with a special purpose acquiring company.
The company announced financial results for the fourth quarter and full year in the first day of this month. Although Babylon reported total revenue of $322.9 million for the full year — compared with $79.3 million in 2020 — it also recorded a loss of $374.5 million. Babylon attributed some of the losses to the one-time costs associated with going public, as well as the need for higher resources to support the new business, going public, and acquisition costs.
“We continue to focus on growth in the US – [our] segmentation of value-based care but also [on] building our software licensing pipeline in 2022 to have revenue by ’23,” Parsa said on the earnings call.
